Soft tissue sarcoma: Clinical practice guidelines in oncology™

George D. Demetri, Laurence H. Baker, Robert S. Benjamin, Ephraim S. Casper, Ernest U. Conrad, Gina Z. D'Amato, Thomas F. DeLaney, David S. Ettinger, Robert Heck, Martin J. Heslin, Ray J. Hutchinson, Charlotte D. Jacobs, Krystyna Kiel, William G. Kraybill, G. Douglas Letson, Richard J. O'Donnell, I. Benjamin Paz, John Pfeifer, Raphael E. Pollock, R. Lor RandallAaron R. Sasson, Karen D. Schupak, Douglas S. Tyler, Margaret Von Mehren, Jeffrey Wayne

Research output: Contribution to journalArticlepeer-review

27 Scopus citations


Soft tissue sarcomas are the most frequent sarcomas; the annual incidence for 2007 in the United States is estimated at about 9220 cases, with an overall mortality rate of approximately 3560 cases per year. Important updates for the 2007 version of the guidelines include the addition of epirubicin (single agent) and the combination of epirubicin, ifosfamide, and mesna as generally accepted systemic therapy. Imatinib was added as an option for desmoid tumors.

Original languageEnglish (US)
Pages (from-to)364-399
Number of pages36
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number4
StatePublished - Apr 2007
Externally publishedYes


  • Chemotherapy
  • Desmoid tumor
  • Gastrointestinal stromal tumors
  • NCCN Clinical Practice Guidelines
  • Radiation therapy
  • Retroperitoneal sarcomas
  • Soft tissue extremity sarcoma
  • Soft tissue sarcoma
  • Surgery

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Soft tissue sarcoma: Clinical practice guidelines in oncology™'. Together they form a unique fingerprint.

Cite this